Semus Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Semus Wealth Partners's ABBV Position: Q3 2026 in Review
Semus Wealth Partners increased its AbbVie (ABBV) stake by 0.12% in Q3 2026, buying an estimated $769 and bringing the position to 2,411 shares worth $631K. The position accounts for 0.29% of the portfolio, ranked #61.
Semus Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Semus Wealth Partners held 2,411 shares of AbbVie worth $631K as of Q3 2026.
- Semus Wealth Partners bought 3 AbbVie shares in Q3 2026, an estimated $769.
- AbbVie made up 0.29% of Semus Wealth Partners's portfolio in Q3 2026, its #61 holding.
- Semus Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Semus Wealth Partners's 13F filing for Q3 2026, filed 22 Oct 2026.